Scientific work

Publications.

Microbial therapeutics, host responses, and the biology between them.

Find me on Google Scholar

2026

  1. Frontiers in Immunology 17, 1925200

    Saccharomyces boulardii reduces food intake and attenuates weight gain in diet-induced obese mice: links to gut microbial, metabolic, and immune remodeling

    KA Hedin, TH Vaaben, DO Lützhøft, BAH Jensen, MOA Sommer

    doi: 10.3389/fimmu.2026.1925200
  2. Gut Microbes 18 (1), 2690687

    Multi-omics analysis of Saccharomyces boulardii supplementation reveals coordinated microbiome, metabolic, and immune signaling changes accompanying tumor suppression

    TH Vaaben, DO Lützhøft, KA Hedin, L Ahonen, R Vazquez-Uribe, MOA Sommer

    doi: 10.1080/19490976.2026.2690687
  3. iScience 29 (5), 115706

    Genomic and phenotypic comparisons reveal lineage-specific traits of the probiotic Saccharomyces boulardii

    HE Duffey, KA Hedin, HP Gelli, TH Vaaben, MOA Sommer

    doi: 10.1016/j.isci.2026.115706

2025

  1. Nature Communications 16 (1), 663

    Metagenome-guided culturomics for the targeted enrichment of gut microbes

    J Armetta, SS Li, TH Vaaben, R Vazquez-Uribe, MOA Sommer

    doi: 10.1038/s41467-024-55668-y
  2. EMBO Reports 26 (7), 1688–1708

    Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite

    TH Vaaben, DO Lützhøft, A Koulouktsis, IM Dawoodi, C Stavnsbjerg, L Kvich, I Gögenur, R Vazquez-Uribe, MOA Sommer

    doi: 10.1038/s44319-025-00386-9
  3. Journal of Agricultural and Food Chemistry 73 (24), 15199–15214

    Advanced Microbiome Therapeutics Accelerate MASLD Recovery by Restoring Intestinal Microbiota Equilibrium and the Gut-Liver Axis in a Mouse Model

    J Lok, C Chen, V Iannone, AF Babu, EKK Lo, R Vazquez-Uribe, TH Vaaben, M Kettunen, O Savolainen, U Schwab, MOA Sommer, K Hanhineva, M Kolehmainen, H El-Nezami, C Gómez-Gallego

    doi: 10.1021/acs.jafc.5c01674

2024

  1. The ISME Journal 18 (1), wrae212

    Saccharomyces boulardii enhances anti-inflammatory effectors and AhR activation via metabolic interactions in probiotic communities

    KA Hedin, MH Mirhakkak, TH Vaaben, C Sands, M Pedersen, A Baker, R Vazquez-Uribe, S Schäuble, G Panagiotou, A Wellejus, MOA Sommer

    doi: 10.1093/ismejo/wrae212

2023

  1. Scientific Reports 13 (1), 12506

    Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy

    S Tumas, TS Meldgaard, TH Vaaben, S Suarez Hernandez, AT Rasmussen, R Vazquez-Uribe, SR Hadrup, MOA Sommer

    doi: 10.1038/s41598-023-39365-2
  2. Molecular Metabolism 78, 101823

    Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

    V Iannone, AF Babu, J Lok, C Gómez-Gallego, G D'Auria, R Vazquez-Uribe, TH Vaaben, M Bongers, S Mikkonen, M Vaittinen, I Tikkanen, M Kettunen, A Klåvus, R Sehgal, D Kaminska, J Pihlajamaki, K Hanhineva, H El-Nezami, MOA Sommer, M Kolehmainen

    doi: 10.1016/j.molmet.2023.101823

2022

  1. ACS Synthetic Biology 11 (12), 4184-4192

    Characterization of eight bacterial biosensors for microbial diagnostic and therapeutic applications

    TH Vaaben, R Vazquez-Uribe, MOA Sommer

    doi: 10.1021/acssynbio.2c00491